PPIA and coronary artery disorder: While the role, mode of action and localization of CypA in cardiovascular diseases is well documented and it has been proposed as a biomarker for CAD, less data are available about other Cyps, in terms of cellular targets or extracellular levels, and the relationship of those when other cardiovascular risk factors are present9,14,16,18.